HealthQuest invests in Inmediata

HealthQuest Capital is pleased to announce the closing of $4 Million of funding for inMediata.   

This capital will be used to expand inMediata’s ongoing development of their healthcare product platforms.  HealthQuest will also be participating as a member of the inMediata Board of Directors.

inMediata, a healthcare payments and EDI company, drives innovation in medical payments by bridging the gap between healthcare EDI and banking.

inMediata CEO Bob Strickland comments, “We are excited to have HealthQuest as a new partner. Their investment will support our efforts to build new innovative technology solutions for the healthcare market”. 

HealthQuest Partner Tom Callaway, MD, MBA, commented on inMediata’s strategy, stating, “Healthcare service providers facing increasing billing complexity are seeking tools to reconcile payments with  insurers,  healthcare providers, and patients with  high deductible plans.   inMediata ‘s 360 solution connects banking data and healthcare EDI for greater transparency and improved collections. We’re pleased to be partnering with this innovative solution provider.”

About HealthQuest Capital
HealthQuest Capital makes go-to-market and early growth investments in innovative healthcare companies that are improving both patient outcomes and healthcare economics. Investments focus on the medical device, diagnostics, patient care products, consumer health/OTC and healthcare IT fields. The HealthQuest investing team includes deep operational, clinical and scientific expertise and worldwide relationships throughout the healthcare industry that can be leveraged to add value to our portfolio companies. HealthQuest Capital is headquartered in Menlo Park, CA with offices in Southern CA, Florida, and Georgia.